This conference forms part of IBC’s Regulatory Series, the longest standing event of its kind in the region. For the first time in 2013, the event will be launched in China, with a focus on North Asia, particularly China, Korea, Japan and Taiwan. The meeting is an opportunity for industry and authorities to discuss and collaborate to achieve efficient market access with a view to deliver safe and effective medicines to the Asian population.
Event highlights:
- One-on-one networking opportunities with regulatory representatives and industry peers
- Sharing of practical regulatory and industry experience – insights that you will not find in guidelines or online
- Latest updates on regional and global issues and what this means for your regulatory strategy
- Variety of topics that impact regulatory professionals including new product registration, variations, CMC, GMP, clinical trials